Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Non-Comparative Study of FK463 for the Treatment of Invasive Aspergillosis

NCT00036166 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00036166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00036166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Non-Comparative Study of FK463 for the Treatment of Invasive Aspergillosis
Lead sponsor
Astellas Pharma Inc
Phase
Phase 2
Overall status
Completed
Start date
January 29, 1999
Completion date
January 31, 2002
Enrollment
326 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

aspergillosis